Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Gaspari T, Welungoda I, Widdop RE, Simpson RW, Dear AE (2013) The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model
1i), validating the dataset
For GLP-1 RAs and other peptides, we see the potential of developing HILIC methods to become part of the analytical workflows for peptides CQA monitoring in GMP and non GMP settings, complementing the information provided by other more common techniques
(40648766) Tumor types: Mesenchymal tumors (~40%), e.g.: Mesothelioma
Dosing before bed is the most common recommendation
US$ 20.60
US$ 27.85
US$ 25.24
US$ 28.17
US$ 25.53
US$ 25.57
US$ 20.56
US$ 23.92
US$ 26.52
US$ 25.80
